All News

NABP effort seeks worldwide protection for consumers and users of pharmacies online.

As hospitals face decreased reimbursements, pharmacist involvement in pre- and post-discharge medication reconciliation is more important than ever.

The law expands the powers of registered pharmacists and establishes a new category of Advanced Practice Pharmacists.

Patch treating overactive bladder in women is now available OTC.

Since the NECC-triggered outbreak of fungal meningitis in 2012, FDA has responded aggressively, inspected almost 70 pharmacies. Now it is supported by a new law, the DQSA, and many new questions arise.

Portola is pursuing accelerated approval for andexanet alfa and plans to initiate studies on a larger scale in 2014.

Three states prepare to handle mushrooming Medicaid enrollments

Some of the medications coming into Maine will originate in countries where oversight of the pharmaceutical production process is lax or nil. Are the possible consequences worth the probable savings?

The U.S. Drug Enforcement Administration is investigating pseudoephedrine sales at Rite Aid stores throughout West Virginia, according to a published report.

FDA has issued a warning that over-the-counter sodium phosphate drugs can cause serious injury to kidneys and the heart if more than one dose is taken in 24 hours.

Springfield, Mass.-based Big Y is the latest retail pharmacy to add special print and audio prescription labels for those with vision impairments. Two of Big Y’s stores in Rocky Hill, Conn., and Longmeadow, Mass., are adding either a large print 'ScripView' label or an electronic 'ScripTalk' label to medications for those with low vision.

A survey of more than 1,000 pharmacists conducted by NCPA reveals high numbers of chronic-pain patients who had to wait or search to fill their prescriptions and pharmacies without supplies to fill them at all.

What if consumers could bypass trips to the pharmacy, eliminating the need to wait in lines while prescriptions are filled or insurance companies are contacted? Well, apparently, there’s now an app for that.

Two big causes drive NCPA's new president.

Gerald Meyer, president of the American Society of Health-System Pharmacists (ASHP), discusses the importance of provider status during an interview at ASHP's Midyear Clinical Meeting in Orlando, Fla.

Members of the American Pharmacists Association (APhA) will meet the 2014 president-elect candidates during the APhA annual meeting and exhibition in Orlando in March.

NCPA has asked congressional leaders to look into the reasons behind the skyrocketing costs of generic drugs.

Researchers say they have linked high testosterone levels in men to a poor immune response to an influenza vaccine.

In the last 10 years, deaths in the ICU from severe pneumococcal pneumonia have decreased notably. Earlier use of antibiotics and more combo therapy have made the difference.

A California judge recently ordered CVS Pharmacy to pay three counties more than $658,000 to settle charges that pharmacists did not properly consult patients filling prescriptions.

More than one million Americans have signed up for coverage under the Affordable Care Act, but many are having difficulty using their coverage because they have not received plan identification numbers from insurers. To aid those in such situations, Walgreens, Wal-Mart, Kroger, and other large and small pharmacies are offering a limited amount of medications at no upfront cost.

Karen Staniforth, a pharmacist with more than 30 years’ experience in retail pharmacy, has been named Rite Aid Corporation’s group vice president, pharmacy Initiatives and clinical services.

In its largest gift ever to AmeriCares, Mylan has donated more than $3 million in medicines to aid that organization’s Typhoon Haiyan relief efforts in the Philippines. The various medicines will be used to treat patients with infections, diabetes, and cardiovascular diseases.

Baxter International has initiated a voluntary recall in the United States of 2 lots of premixed sterile intravenous (IV) parenteral nutrition products: CLINIMIX (Amino Acid in Dextrose) Injection and CLINIMIX E (Amino Acid with Electrolytes in Dextrose with Calcium) Injections to the user level because of complaints of particulate matter found in the products.

FDA approved 27 new drugs last year, down from 39 new medications in 2012, which was a 15-year high, the Associated Press reported.